Posts from VC News Daily for 07/02/2026

1. Key Themes

AI Inference Infrastructure Is Attracting Mega-Rounds

The single largest capital concentration in this digest is in AI inference — the layer that serves model outputs at scale. Two companies alone raised $2.15 billion in a single day.

• "Together AI, the company making it dramatically cheaper and easier to run open source AI models at scale, announced an $800 million Series C financing at an $8.3 billion post-money valuation."
• "Baseten, the AI inference company powering advanced AI applications, announced a $1.5 billion Series F financing led by Altimeter Capital, Conviction, and Spark Capital."
• "Groq announced $650 million in new growth capital to accelerate the expansion of its AI inference cloud."

Physical AI and Robotics Are Moving From Hype to Funded Reality

Capital is flowing into companies that bring AI into the physical world — manufacturing, industrial automation, and consumer services — signaling a maturation beyond software-only AI plays.

• "CarbonSix, a pioneer in Physical AI for the manufacturing sector, announced that it has raised $40 million in a Series A funding round."
• "Luxonis, the robotics and industrial automation company behind the OAK camera and DepthAI software, today announced the close of a $14 million Series A round."
• "10Beauty, the robotics company behind the first full-service robotic manicure, has raised $23.5 million in new funding."

AI Is Penetrating Vertical, Domain-Specific Markets

Beyond horizontal infrastructure, investors are funding AI applied to specific regulated or data-intensive industries: finance, legal, collections, and public markets.

• "KredosAi, an AI-powered collections platform that enhances revenue recovery by leveraging behavioral intelligence, has announced the close of a $7 million Series A funding round."
• "LinqAlpha, the AI-native company building the Alpha Intelligence Layer for global public markets, today announced $22 million in Series A funding."
• "Turbo Law, the unified litigation platform for complex litigation, today announced a $3.8 million pre-seed round."

Biotech Remains a Robust, High-Capital Category

Despite AI dominating headlines, life sciences continues to command large rounds, particularly in clinical-stage companies targeting diseases with unmet medical need.

• "Ollin Biosciences, a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, announced an oversubscribed $330 million Series B financing."
• Recent articles also reference "Osanni Bio Closes $190 Million Series B" and "Mirendil Snares $200M Seed Funding" — the latter being a remarkably large seed for biotech.

---

2. Contrarian Perspectives

Late-Stage AI Infrastructure Valuations Are Compressing Relative to Round Size Together AI raised $800M at an $8.3B post-money valuation — a roughly 10x revenue multiple implied by scale, but notably modest for an AI company in 2025–2026 terms. Meanwhile, AppsFlyer raised over $1 billion at only a $2.7B post-money valuation, suggesting investors are demanding more disciplined pricing even at large check sizes.

• "AppsFlyer has raised more than $1 billion in Series E funding at a $2.7 billion post-money valuation."
• This is a post-money valuation lower than Together AI's despite being a more mature Series E — suggesting the market is bifurcating between AI-premium and non-AI-discount pricing.

Seed Rounds Are No Longer Small — The Definition of Early Stage Has Shifted The presence of a $200M seed round (Mirendil) and a $320M Series A (General Intuition) in the recent articles list signals that "early stage" now encompasses what used to be growth-stage capital. This compresses the traditional VC return model.

• "Mirendil Snares $200M Seed Funding" — a seed round at a scale that would have been considered a Series C just five years ago.
• "General Intuition Banks $320M Series A" — further evidence that round labels are losing their traditional meaning.

Robotics Is Finding Consumer Wedges, Not Just Industrial Ones The conventional wisdom is that robotics ROI is clearest in industrial/manufacturing settings. 10Beauty challenges this by targeting the consumer personal-care market — a fragmented, labor-intensive sector that has not historically been a robotics focus.

• "10Beauty, the robotics company behind the first full-service robotic manicure, has raised $23.5 million in new funding."

---

3. Companies Identified

---

4. People Identified

No specific individuals are named or profiled in this edition of the newsletter. The content is limited to deal announcements without attributed executives or investors.

---

5. Operating Insights

Positioning Around "Cost Reduction" Is a Fundraising Accelerant in AI Infrastructure Together AI's framing — "making it dramatically cheaper and easier to run open source AI models at scale" — is a durable value proposition that justifies enterprise adoption and investor confidence simultaneously. Cost efficiency as a core narrative (not just capability) is resonating at the highest capital levels.

• "Together AI, the company making it dramatically cheaper and easier to run open source AI models at scale, announced an $800 million Series C financing."

The "Oversubscribed" Signal Still Matters in Biotech In a market where many rounds are quietly structured, Ollin Biosciences calling out an oversubscribed round is a deliberate signal of demand exceeding supply — useful for downstream partnership negotiations, talent recruitment, and commercial credibility.

• "Ollin Biosciences…announced an oversubscribed $330 million Series B financing."

Vertical AI Platforms Should Anchor to a Specific, Measurable Outcome The highest-conviction vertical AI raises in this digest are anchored to a concrete business metric: collections recovery (KredosAi), alpha generation (LinqAlpha), litigation management (Turbo Law). Vague "AI for X" positioning is absent from funded companies here.

• "KredosAi…enhances revenue recovery by leveraging behavioral intelligence."
• "LinqAlpha…building the Alpha Intelligence Layer for global public markets."

---

6. Overlooked Insights

AppsFlyer's $1B+ Raise at a Relatively Modest Valuation Deserves Scrutiny AppsFlyer is a mature, well-known mobile measurement and attribution company — not a new AI entrant. Raising over $1 billion at a $2.7B post-money valuation at Series E suggests either a significant valuation reset from prior marks, a structured deal with downside protection, or a pre-IPO liquidity event. This is an outlier worth watching as a bellwether for how non-AI SaaS is being repriced.

• "AppsFlyer has raised more than $1 billion in Series E funding at a $2.7 billion post-money valuation."

Luxonis's Dual Hardware + Software Stack Is a Rare Moat in Robotics Most robotics investment goes to pure software or pure hardware plays. Luxonis owns both the OAK camera (hardware) and DepthAI (software), which creates tighter integration, higher switching costs, and a more defensible margin structure — yet it raised only $14M, suggesting it may be significantly undervalued relative to peers.

• "Luxonis, the robotics and industrial automation company behind the OAK camera and DepthAI software, today announced the close of a $14 million Series A round."